Review vaccine policy to safest vaccine: Experts to govt
India should review its vaccine policy to favour the safest vaccine of all the vaccines that have been approved for the coronavirus, says expert.
coronavirus
March 2022
February 2022
December 2021
May 2021
January 2021
November 2020
Covid-19 cases rising in SE Asia, China, Europe, U.S. as another wave looms large
During the week ending March 13, the number of new weekly cases has increased by 8% as compared to the previous week, says WHO.
Covid-19 pandemic's third wave in India waning
The daily positivity rate has come down to just over 5.02% and the weekly positivity rate has come down to 8.30%.
Copper vessels, Nitric Oxide can kill coronavirus, say studies
Inhaled Nitric Oxide (iNO) is virucidal and kills SARS-COV-2 virus, apart from preventing its effective attachment to human host cells, says study.
Delhi, Gujarat, TN, W Bengal, Maha among 8 states with spike in Omicron; Centre sounds alert
Centre has asked eight states to proactively address the spurt in Covid-19 cases to avoid large scale transmission and increased mortality rates.
Pfizer oral pill for Covid-19 gets US FDA approval
Company to increase production of Paxlovid from 80 million to 120 million courses of treatment in 2022; plans to launch worldwide with voluntary licenses to other manufacturers
Life and death beyond networks
Indians have always trusted personal networks and connections more than public goods and governance. Covid-19 should shake that belief.
Building the Metropolis of the future
Ameera Shah's Metropolis Healthcare is all set to acquire Hitech Diagnostics Centre. Here's Fortune India's earlier story on how Shah is transforming her fast-growing pathlab company.
Hope and prayer: Race for the Covid-19 vaccine
As the world awaits a panacea for Covid-19, pharma companies have their feet firmly on the accelerator to get people a safe vaccine to stem the spiral of death and illness looming over humanity.
Economic recovery: India’s arduous ascent
The signs of a pick-up hold out hope, but regaining lost ground is the tough task ahead.
